Flextem Biopharma: innovation and commitment to quality

Flextem Biopharma, a pharmaceutical company founded in 2018, has established itself as a pioneer in the research, cultivation, and production of high-quality pharmaceutical-grade cannabis in Uruguay. With all its operations in the free trade zone of Colonia del Sacramento, the company is ready for a new milestone in its journey, its inaugural participation in the Medical Cannabis Fair (MCF), one of the most significant professional scientific events in Latin America.

As a vertically integrated company, Flextem controls all stages of the process, from the genetic development of the plants to the manufacturing of finished products.  

“We are proud to have a diverse and highly skilled team, whose collaborative work has resulted in a unique system that applies innovative production techniques in state-of-the-art facilities, covering over 4,000 square meters of production area,” highlights Agustín Trajtenberg, founder and CEO of the company.

Mission and participation in the Medical Cannabis Fair 2024

Amid preparations for this year's Medical Cannabis Fair, Trajtenberg shares his vision regarding the company's mission and the relevance of this emblematic event.  

"Our mission is clear: to provide high-quality cannabis products for medicinal use and scientific research, meeting the needs of patients and partners at both regional and global levels," states the CEO.

He further emphasizes the importance of Flextem's participation in the MCF as a crucial step towards achieving this goal. "This fair represents a unique opportunity for us to showcase our advancements, share knowledge, and establish vital connections within the scientific and professional community of medicinal cannabis. We look forward to contributing to the dialogue and further advancing the standards of quality and innovation in this rapidly evolving industry."

Commitment to quality and international recognition

Throughout its journey, Flextem has achieved several significant milestones in terms of quality and regulatory compliance. The company has obtained Good Manufacturing Practices (GMP) certification for all post-harvest and drug manufacturing stages, issued by the Ministry of Public Health of Uruguay (MSP). Additionally, its in-house quality control laboratory has secured certifications in Good Laboratory Practices for the pharmaceutical industry.

One of the most notable achievements was obtaining the Good Agricultural and Collection Practices (GACP) certification for medicinal cannabis, issued by Control Union Certifications, in compliance with the standards of the World Health Organization (WHO) and the European Medicines Agency (EMA).

Flextem's participation in the Medical Cannabis Fair not only consolidates its position as a leader in the medicinal cannabis industry but also reinforces its unwavering commitment to quality, innovation, and excellence in all aspects of its operations.